Table 2 EoL chemotherapy and PS ECOG distribution
Total No. (%) | New CT scheme prescription > 30 days to death No. (%) | New CT scheme prescription ≤30 days to death No. (%) | p-value | Total No. (%) | Last CT cycle administration > 14 days to death No. (%) | Last CT cycle administration ≤14 days to death No. (%) | p-value | |
|---|---|---|---|---|---|---|---|---|
Overall | 192 (100.0) | 170 (88.5) | 22 (11.5) | 129 (100.0) | 115 (89.1) | 14 (10.9) | ||
PS (ECOG) | ||||||||
0 | 78 (40.6) | 75 (96.2) | 3 (3.8) | < 0.01 | 34 (26.4) | 32 (94.1) | 2 (5.9) | 0.01 |
1 | 80 (41.7) | 74 (92.5) | 6 (7.5) | 57 (44.2) | 51 (89.5) | 6 (10.5) | ||
2 | 28 (14.6) | 18 (64.3) | 10 (35.7) | 35 (27.1) | 30 (85.7) | 5 (14.3) | ||
3 | 6 (3.1) | 3 (50.0) | 3 (50.0) | 3 (2.3) | 2 (66.7) | 1 (33.3) | ||